Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, California 92037, USA; email:
Department of Genomics, Stem Cell Biology and Regenerative Medicine, Institute of Molecular Biology, and Center for Molecular Biosciences Innsbruck, University of Innsbruck, A-6020 Innsbruck, Austria.
Annu Rev Genet. 2018 Nov 23;52:271-293. doi: 10.1146/annurev-genet-120417-031534. Epub 2018 Sep 12.
Age-associated neurological diseases represent a profound challenge in biomedical research as we are still struggling to understand the interface between the aging process and the manifestation of disease. Various pathologies in the elderly do not directly result from genetic mutations, toxins, or infectious agents but are primarily driven by the many manifestations of biological aging. Therefore, the generation of appropriate model systems to study human aging in the nervous system demands new concepts that lie beyond transgenic and drug-induced models. Although access to viable human brain specimens is limited and induced pluripotent stem cell models face limitations due to reprogramming-associated cellular rejuvenation, the direct conversion of somatic cells into induced neurons allows for the generation of human neurons that capture many aspects of aging. Here, we review advances in exploring age-associated neurodegenerative diseases using human cell reprogramming models, and we discuss general concepts, promises, and limitations of the field.
与年龄相关的神经退行性疾病是生物医学研究中的一个巨大挑战,因为我们仍在努力理解衰老过程与疾病表现之间的关系。老年人的各种病变并非直接由基因突变、毒素或感染因子引起,而是主要由生物衰老的多种表现所驱动。因此,需要新的概念来生成合适的模型系统,以研究神经系统中的人类衰老,这些概念超越了转基因和药物诱导模型。尽管获取可行的人脑标本受到限制,并且由于与重编程相关的细胞年轻化,诱导多能干细胞模型也存在局限性,但将体细胞直接转化为诱导神经元可以产生捕获衰老许多方面的人类神经元。在这里,我们回顾了使用人类细胞重编程模型探索与年龄相关的神经退行性疾病的进展,并讨论了该领域的一般概念、前景和局限性。